Detalhe da pesquisa
1.
Therapy-induced APOBEC3A drives evolution of persistent cancer cells.
Nature
; 620(7973): 393-401, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407818
2.
NET Rounding: a novel approach to efficient and effective rounds for the modern clinical learning environment.
BMC Med Educ
; 22(1): 600, 2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927659
3.
Lectin-like oxidized low-density lipoprotein receptor (LOX-1) in sickle cell disease vasculopathy.
Blood Cells Mol Dis
; 60: 44-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27519944
4.
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer.
Cancer Discov
; 8(12): 1598-1613, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30254092
5.
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM.
Clin Cancer Res
; 24(1): 197-208, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051323
6.
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition.
Nat Med
; 22(3): 262-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26828195